1. Home
  2. COCO vs NUVB Comparison

COCO vs NUVB Comparison

Compare COCO & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

HOLD

Current Price

$53.69

Market Cap

3.1B

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$8.93

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCO
NUVB
Founded
2004
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.9B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
COCO
NUVB
Price
$53.69
$8.93
Analyst Decision
Buy
Strong Buy
Analyst Count
9
8
Target Price
$55.13
$10.63
AVG Volume (30 Days)
623.0K
6.1M
Earning Date
10-29-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
15.16
N/A
EPS
1.15
N/A
Revenue
$609,286,000.00
$26,748,000.00
Revenue This Year
$18.22
$609.55
Revenue Next Year
$13.69
$197.91
P/E Ratio
$46.37
N/A
Revenue Growth
23.12
1137.19
52 Week Low
$25.79
$1.54
52 Week High
$55.29
$9.75

Technical Indicators

Market Signals
Indicator
COCO
NUVB
Relative Strength Index (RSI) 58.27 61.16
Support Level $52.87 $9.06
Resistance Level $54.89 $9.75
Average True Range (ATR) 1.33 0.44
MACD -0.36 -0.09
Stochastic Oscillator 61.66 58.21

Price Performance

Historical Comparison
COCO
NUVB

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: